KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Change in Accured Expenses (2016 - 2025)

Sarepta Therapeutics has reported Change in Accured Expenses over the past 15 years, most recently at $249.6 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 100.96% year-over-year to $249.6 million; the TTM value through Dec 2025 reached $104.3 million, down 5.77%, while the annual FY2025 figure was $104.3 million, 5.77% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was $249.6 million at Sarepta Therapeutics, up from -$103.2 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $249.6 million in Q4 2025 and troughed at -$103.2 million in Q3 2025.
  • A 5-year average of $16.8 million and a median of -$1.7 million in 2022 define the central range for Change in Accured Expenses.
  • Biggest five-year swings in Change in Accured Expenses: soared 396.97% in 2024 and later tumbled 6223.03% in 2025.
  • Year by year, Change in Accured Expenses stood at $69.8 million in 2021, then tumbled by 81.55% to $12.9 million in 2022, then soared by 374.36% to $61.1 million in 2023, then soared by 103.34% to $124.2 million in 2024, then skyrocketed by 100.96% to $249.6 million in 2025.
  • Business Quant data shows Change in Accured Expenses for SRPT at $249.6 million in Q4 2025, -$103.2 million in Q3 2025, and -$24.5 million in Q2 2025.